These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35156873)
61. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease. Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160 [TBL] [Abstract][Full Text] [Related]
62. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients. Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335 [TBL] [Abstract][Full Text] [Related]
64. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024 [TBL] [Abstract][Full Text] [Related]
65. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Stocco G; Crews KR; Evans WE Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291 [TBL] [Abstract][Full Text] [Related]
66. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872 [TBL] [Abstract][Full Text] [Related]
67. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187 [TBL] [Abstract][Full Text] [Related]
69. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Moriyama T; Nishii R; Perez-Andreu V; Yang W; Klussmann FA; Zhao X; Lin TN; Hoshitsuki K; Nersting J; Kihira K; Hofmann U; Komada Y; Kato M; McCorkle R; Li L; Koh K; Najera CR; Kham SK; Isobe T; Chen Z; Chiew EK; Bhojwani D; Jeffries C; Lu Y; Schwab M; Inaba H; Pui CH; Relling MV; Manabe A; Hori H; Schmiegelow K; Yeoh AE; Evans WE; Yang JJ Nat Genet; 2016 Apr; 48(4):367-73. PubMed ID: 26878724 [TBL] [Abstract][Full Text] [Related]
70. The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs. von Muhlenbrock C; Estay C; Covarrubias N; Miranda J; Venegas M Pharmacogenet Genomics; 2023 Sep; 33(7):161-163. PubMed ID: 37556121 [TBL] [Abstract][Full Text] [Related]
71. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378 [TBL] [Abstract][Full Text] [Related]
72. NUDT15 genetic testing-guided 6-mercaptopurine dosing in children with ALL likely to be cost-saving in China. Wei X; Zhuang J; Li N; Zheng B; Sun H; Cai J; Huang X; Zhang G; Zhuang J Int J Hematol; 2022 Feb; 115(2):278-286. PubMed ID: 34709580 [TBL] [Abstract][Full Text] [Related]
73. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. Shah SA; Paradkar M; Desai D; Ashavaid TF J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873 [TBL] [Abstract][Full Text] [Related]
74. APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia. Kim H; Seo H; Park Y; Min BJ; Seo ME; Park KD; Shin HY; Kim JH; Kang HJ Cancer Res Treat; 2018 Jul; 50(3):823-834. PubMed ID: 28882023 [TBL] [Abstract][Full Text] [Related]
75. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia. Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697 [TBL] [Abstract][Full Text] [Related]
76. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. Kakuta Y; Kinouchi Y; Shimosegawa T J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347 [TBL] [Abstract][Full Text] [Related]
77. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis. Jena A; Jha DK; Kumar-M P; Kasudhan KS; Kumar A; Sarwal D; Mishra S; Singh AK; Bhatia P; Patil A; Sharma V Expert Rev Clin Pharmacol; 2021 Apr; 14(4):491-501. PubMed ID: 33682590 [No Abstract] [Full Text] [Related]
78. NUDT15 polymorphism in healthy children with Bai nationality in Yunnan of China. Pu G; Wang Y; Duan S; Chen J; Yang C; Cui T; Fang C; Zhou Y; Zhang H; Tian X Pediatr Int; 2021 Jul; 63(7):790-796. PubMed ID: 32969567 [TBL] [Abstract][Full Text] [Related]
79. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease. Zhu X; Wang XD; Chao K; Zhi M; Zheng H; Ruan HL; Xin S; Ding N; Hu PJ; Huang M; Gao X Aliment Pharmacol Ther; 2016 Nov; 44(9):967-975. PubMed ID: 27604507 [TBL] [Abstract][Full Text] [Related]
80. Role of TPMT and ITPA variants in mercaptopurine disposition. Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]